2024 Grants Program

In October 2023, the Consortium released a Request for Proposals (RFP) for research proposals from investigators at the different Consortium member institutions.

The Consortium for Medical Marijuana Clinical Outcomes Research (Consortium) received 26 proposals in response to its 2024 Request for Proposals (RFP), submitted by investigators from different Consortium member institutions. These proposals were reviewed by ad-hoc out-of-state faculty reviewers with demonstrated expertise in the respective research area using NIH criteria for scientific review of research proposals. Funding recommendations were made after careful consideration of the merit of each proposal and its contribution to the consortium research mission by the Consortium board. The Consortium research mission per statute is to contribute to understanding the effects of medical marijuana use and to promote informed decisions regarding policy and clinical practice related to the treatment of debilitating medical conditions with marijuana.

Six new awards along with two Level-2 renewals will be made in the 2024 cycle of the Medical Marijuana Clinical Outcomes Research Consortium Grants Program. Below is the list of proposal titles, principal investigators, and respective member institutions.